BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8359227)

  • 1. The close relationship between DNA replication and the selection of differentiation lineages of human erythroleukemia cell lines K562, HEL, and TF1 into either erythroid or megakaryocytic lineages.
    Murate T; Saga S; Hotta T; Asano H; Ito T; Kato K; Tsushita K; Kinoshita T; Ichikawa A; Yoshida S
    Exp Cell Res; 1993 Sep; 208(1):35-43. PubMed ID: 8359227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aphidicolin, an inhibitor of DNA replication, blocks the TPA-induced differentiation of a human megakaryoblastic cell line, MEG-O1.
    Murate T; Hotta T; Tsushita K; Suzuki M; Yoshida T; Saga S; Saito H; Yoshida S
    Blood; 1991 Dec; 78(12):3168-77. PubMed ID: 1742484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional role of mitogen-activated protein kinases, erk1 and erk2, in the differentiation of a human leukemia cell line, UT-7/GM: a possible key factor for cell fate determination toward erythroid and megakaryocytic lineages.
    Uchida M; Kirito K; Shimizu R; Miura Y; Ozawa K; Komatsu N
    Int J Hematol; 2001 Jan; 73(1):78-83. PubMed ID: 11372759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells.
    Hong Y; Martin JF; Vainchenker W; Erusalimsky JD
    Blood; 1996 Jan; 87(1):123-31. PubMed ID: 8547633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of megakaryocytic and erythroid properties in human leukemic cells.
    Tani T; Ylänne J; Virtanen I
    Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
    Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: a novel experimental model for hemopoietic lineage restriction.
    Green AR; Rockman S; DeLuca E; Begley CG
    Exp Hematol; 1993 Apr; 21(4):525-31. PubMed ID: 8462662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation.
    Ikonomi P; Rivera CE; Riordan M; Washington G; Schechter AN; Noguchi CT
    Exp Hematol; 2000 Dec; 28(12):1423-31. PubMed ID: 11146164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alpha1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells.
    Fuchs R; Stelzer I; Haas HS; Leitinger G; Schauenstein K; Sadjak A
    Ann Hematol; 2009 Oct; 88(10):989-97. PubMed ID: 19241077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
    Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW
    Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α1-Adrenergic drugs modulate differentiation and cell death of human erythroleukemia cells through non adrenergic mechanism.
    Fuchs R; Schraml E; Leitinger G; Stelzer I; Allard N; Haas HS; Schauenstein K; Sadjak A
    Exp Cell Res; 2011 Oct; 317(16):2239-51. PubMed ID: 21781962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells.
    Delgado MD; Quincoces AF; Gómez-Casares MT; Martínez CA; Cuadrado MA; Richard C; León J
    Cancer Res; 1992 Nov; 52(21):5979-84. PubMed ID: 1394224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of both erythroid and megakaryocytic differentiation of a human leukemia cell line, UT-7.
    Miura Y; Kirito K; Komatsu N
    Acta Haematol; 1998; 99(3):180-4. PubMed ID: 9587401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive expression of a megakaryocytic functional property by murine erythroleukemia (Friend) cells: the incorporation of serotonin.
    Vannucchi AM; Grossi A; Paoletti F; Rafanelli D; Bacci P; Ferrini PR
    Exp Hematol; 1992 Dec; 20(11):1296-301. PubMed ID: 1493858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDDO-Im is a stimulator of megakaryocytic differentiation.
    Petronelli A; Pelosi E; Santoro S; Saulle E; Cerio AM; Mariani G; Labbaye C; Testa U
    Leuk Res; 2011 Apr; 35(4):534-44. PubMed ID: 21035854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEL/ETV6 accelerates erythroid differentiation and inhibits megakaryocytic maturation in a human leukemia cell line UT-7/GM.
    Takahashi W; Sasaki K; Kvomatsu N; Mitani K
    Cancer Sci; 2005 Jun; 96(6):340-8. PubMed ID: 15958056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminal differentiation of human erythroleukemia cell line K562 induced by aphidicolin.
    Murate T; Kagami Y; Hotta T; Yoshida T; Saito H; Yoshida S
    Exp Cell Res; 1990 Nov; 191(1):45-50. PubMed ID: 2121512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response.
    Okafuji K; Kaku K; Seguchi M; Tanaka H; Azuno Y; Kaneko T
    Exp Hematol; 1995 Mar; 23(3):210-6. PubMed ID: 7875239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of hematopoietic lineage-specific gene expression by ES cell in vitro differentiation induction system.
    Era T; Takagi T; Takahashi T; Bories JC; Nakano T
    Blood; 2000 Feb; 95(3):870-8. PubMed ID: 10648398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained c-kit expression in a human erythroleukemia cell line (HEL) after megakaryocytic differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA).
    Bakić M; Ozawa K; Uemura N; Nishikawa M; Tojo A; Takahashi K; Tani K; Zaike Y; Ikebuchi K; Asano S
    Leuk Res; 1993 Dec; 17(12):1079-82. PubMed ID: 7504152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.